Type of control : Active/Placebo/Active + placebo/No therapy | ||||||
OUTCOMES ASSESSED: Definition of outcome assessed: |
||||||
Primary outcomes: Secondary outcomes Outcome not specified: |
||||||
REASONS FOR EXCLUSION OFSTUDY FROM REVIEW ACCORDING TO PROTOCOL | ||||||
Method |
No RCT / Other |
|||||
Participant related | Not postpartum women | |||||
Outcomes |
|
|||||
Others: | Duplication, etc | |||||
TRIAL CHARACTERISTICS | ||||||
Sample size : | Study design: | |||||
No. randomised: | No. excluded: | Funding: | ||||
Recruitment method : |
|
|||||
Length of follow‐up = from ‐‐‐‐ to ‐‐‐‐‐ | Conflict of interest statement: |
|||||
No. of drop‐outs = Reasons for drop‐out NR |
Loss to follow‐up symmetric in both arms? | |||||